Novel Treatments for Neuromuscular Disorders

 

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for muscle cramps, spasms and spasticity associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 

Spotlight

March 26, 2018 Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in Multiple Sclerosis
Read More

March 7, 2018 Flex Pharma Reports Year End 2017 Financial Results
Read More

February 8, 2018 NEW STUDY SHOWS HOTSHOT® PROVIDES RELIEF FROM MUSCLE SORENESS FOR ATHLETES OF ALL TYPES
Read More

November 28, 2017 Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS
Read More

November 6, 2017 Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS
Read More